Last Updated: October 26, 2026

Dainik Savera Times Logo

  • Tag: Keytruda

    Personalised mRNA Cancer Vaccine Shows Promise in Melanoma as Moderna-Merck Report Positive Phase 3 Results

    Moderna and Merck report positive Phase 3 results for personalised mRNA therapy intismeran autogene with Keytruda, showing improved recurrence-free survival in melanoma.